Therefore, defects in leptin action, which occur in a state of hepatic leptin resistance, impair hepatic function and lead to hyperglycemia, hyperinsulinemia, and dyslipidemia (Frühbeck and Nutr, 2002). Here, LEP is linked to metabolic syndrome.